Pharmaron Beijing Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 4,634.59 million compared to CNY 3,285.51 million a year ago. Net income was CNY 585.43 million compared to CNY 564.84 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.75 CNY | -1.00% | +3.08% | -31.85% |
Apr. 30 | Pharmaron Beijing's Profit Rises 17% in 2023 | MT |
Apr. 29 | Nomura Adjusts Pharmaron’s Price Target to 31.41 Yuan From 36.68 Yuan, Keeps at Buy | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.85% | 4.44B | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- 300759 Stock
- News Pharmaron Beijing Co., Ltd.
- Pharmaron Beijing Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022